1. Home
  2. FARM vs SNTI Comparison

FARM vs SNTI Comparison

Compare FARM & SNTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Farmer Brothers Company

FARM

Farmer Brothers Company

HOLD

Current Price

$1.28

Market Cap

28.3M

ML Signal

HOLD

Logo Senti Biosciences Inc.

SNTI

Senti Biosciences Inc.

HOLD

Current Price

$1.00

Market Cap

29.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FARM
SNTI
Founded
1912
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Packaged Foods
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
28.3M
29.8M
IPO Year
1994
2021

Fundamental Metrics

Financial Performance
Metric
FARM
SNTI
Price
$1.28
$1.00
Analyst Decision
Buy
Strong Buy
Analyst Count
2
4
Target Price
$2.75
$8.50
AVG Volume (30 Days)
191.2K
174.9K
Earning Date
05-07-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
77.31
EPS
N/A
N/A
Revenue
$342,281,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$0.57
N/A
P/E Ratio
N/A
N/A
Revenue Growth
0.35
N/A
52 Week Low
$1.21
$0.77
52 Week High
$2.06
$3.88

Technical Indicators

Market Signals
Indicator
FARM
SNTI
Relative Strength Index (RSI) 52.14 50.57
Support Level $1.21 $0.78
Resistance Level $1.58 $1.02
Average True Range (ATR) 0.01 0.07
MACD 0.01 -0.00
Stochastic Oscillator 75.00 52.29

Price Performance

Historical Comparison
FARM
SNTI

About FARM Farmer Brothers Company

Farmer Bros Co is engaged in manufacturing, wholesaling, and distributing coffee, tea, and culinary products to food-service establishments and retailers in the United States. The company's customers include restaurants, hotels, offices, casinos, convenience stores, healthcare facilities, and other food-service providers. The company's product categories include roast and ground coffee, frozen liquid coffee, flavored and unflavored iced and hot teas, culinary products, spices, and other beverages, such as cappuccino, cocoa, granitas, and ready-to-drink iced coffee.

About SNTI Senti Biosciences Inc.

Senti Biosciences Holdings Inc, formerly known as Senti Biosciences Inc, is a clinical-stage biotechnology company developing cell and gene therapies using its gene circuit platform for patients with incurable diseases. Its gene circuits, created from proprietary DNA sequences, are designed to reprogram cells to sense, compute, and respond to cellular environments. Its product candidates are to kill cancer cells, spare healthy cells, increase specificity, and control drug expression. Its candidate, SENTI-202, is a logic-gated off-the-shelf CAR-NK cell therapy for blood cancers, currently in a Phase 1 clinical trial in the United States and Australia for relapsed or refractory hematological malignancies, including Acute Myeloid Leukemia (AML).

Share on Social Networks: